Human volunteers breathed metered aerosols of Q fever or tularemia organisms through ports along the perimeter of the sphere.
According to USAMRIID, the Whitecoat operation contributed to vaccines approved by the U.S. Food and Drug Administration (FDA) for yellow fever and hepatitis, and investigational drugs for Q fever, Venezuelan equine encephalitis, Rift Valley fever, and tularemia.